Ignite Creation Date:
2025-12-24 @ 7:18 PM
Ignite Modification Date:
2026-01-02 @ 3:10 PM
Study NCT ID:
NCT00676403
Status:
COMPLETED
Last Update Posted:
2021-02-10
First Post:
2008-05-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Lyrica Dose Response Study With Restless Legs Syndrome (RLS) Patients
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-04
Start Date Type:
None
Primary Completion Date:
2009-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-01
Completion Date Type:
ACTUAL
First Submit Date:
2008-05-08
First Submit QC Date:
None
Study First Post Date:
2008-05-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-01-08
Results First Submit QC Date:
None
Results First Post Date:
2010-02-04
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-21
Last Update Post Date:
2021-02-10
Last Update Post Date Type:
ACTUAL